JONATHAN C JAVITT
Medical Practice in Washington, DC
License number
Pennsylvania MD032324E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
Washington, DC 20007
Pennsylvania
Pennsylvania
Personal information
See more information about JONATHAN C JAVITT at radaris.comName
Address
Phone
1700 Pennsylvania Ave NW, Washington, DC 20006
Organization information
See more information about JONATHAN C JAVITT at bizstanding.comOfc of Jonathan C Javitt MD
Washington, DC
Industry:
Medical Doctor's Office, Nonclassifiable Establishments
Addresses:
1701 Pennsylvania Ave NW, Washington, DC 20006
1701 Penn Ave NW, Washington, DC 20006
1701 Penn Ave NW, Washington, DC 20006
Medical Doctor, Principal:
Jonathan Javitt (Medical Doctor, Principal)
Professional information
Ceo And Vice Chairman At Telcare, Llc Senior Fellow At Potomac Institute For Policy Studies Chairman At Health Directions Professor Of Ophthalmology (Adj) At Johns Hopkins University See Less... 1 More...
Location:
Washington D.C. Metro Area
Industry:
Biotechnology
Experience:
Telcare, LLC (Privately Held; Medical Devices industry): CEO and Vice Chairman, (January 2009-Present) TELCARE uses cellular wireless technology to link Americans with chronic illness to caregivers. By transforming the management of chronic illness from inefficient and episodic...
Topical Compositions For The Eye Comprising A .Beta.-Cyclodextrin Derivative And A Therapeutic Agent
US Patent:
5494901, Feb 27, 1996
Filed:
Jan 5, 1993
Appl. No.:
8/000935
Inventors:
Jonathan C. Javitt - Washington DC
Norman B. Javitt - New York NY
Peter McDonnell - Los Angeles CA
Norman B. Javitt - New York NY
Peter McDonnell - Los Angeles CA
International Classification:
A61K 31715, A61K 3170
US Classification:
514 58
Abstract:
A topical composition comprising an amount of a carbonic anhydrase inhibitor and an amount of. beta. -cyclodextrin derivative effective in increasing the bioavailability of the carbonic anhydrase inhibitor when coadministered topically to the eye.
Topical Compositions For The Eye Comprising A .Beta.-Cyclodextrin Derivative And A Therapeutic Agent
US Patent:
5418225, May 23, 1995
Filed:
Jan 5, 1993
Appl. No.:
8/000935
Inventors:
Jonathan C. Javitt - Washington DC
Norman B. Javitt - New York NY
Peter McDonnell - Los Angeles CA
Norman B. Javitt - New York NY
Peter McDonnell - Los Angeles CA
International Classification:
A61K 31715, A61K 3170
US Classification:
514 58
Abstract:
A topical composition comprising an amount of a carbonic anhydrase inhibitor and an amount of. beta. -cyclodextrin derivative effective in increasing the bioavailability of the carbonic anhydrase inhibitor when coadministered topically to the eye.
Dr. Jonathan C Javitt, Bethesda MD - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
2 Bethesda Metro Ctr SUITE 1350, Bethesda 20814
(202) 340-1352 (Phone)
8300 Twin Forks Ln, Chevy Chase 20815
JONATHAN JAVITT MD
1701 Pennsylvania Ave NW SUITE 400, Washington 20006
(202) 349-1477 (Phone), (240) 220-0729 (Fax)
(202) 340-1352 (Phone)
8300 Twin Forks Ln, Chevy Chase 20815
JONATHAN JAVITT MD
1701 Pennsylvania Ave NW SUITE 400, Washington 20006
(202) 349-1477 (Phone), (240) 220-0729 (Fax)
Certifications:
Ophthalmology, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Weill Cornell Medical College
Graduated: 1982
Lenox Hill Hospital
Wills Eye Hosp
Harvard U
Wilmer Inst/Johns Hopkins
Weill Cornell Medical College
Graduated: 1982
Lenox Hill Hospital
Wills Eye Hosp
Harvard U
Wilmer Inst/Johns Hopkins
Jonathan C Javitt, Washington DC
Specialties:
Ophthalmologist
Address:
1701 Pennsylvania Ave Nw, Washington, DC 20006
2 Bethesda Metro Ctr, Bethesda, MD 20814
2 Bethesda Metro Ctr, Bethesda, MD 20814